Biology of Macrofungi [electronic resource] / edited by Bhim Pratap Singh, Lallawmsanga, Ajit Kumar Passari.

Colaborador(es): Singh, Bhim Pratap [editor.] | Lallawmsanga [editor.] | Passari, Ajit Kumar [editor.] | SpringerLink (Online service)Tipo de material: TextoTextoSeries Fungal BiologyEditor: Cham : Springer International Publishing : Imprint: Springer, 2018Edición: 1st ed. 2018Descripción: XVIII, 406 p. 65 illus., 43 illus. in color. online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9783030026226Tema(s): Mycology | Plant anatomy | Plant development | Plant breeding | Plant systematics | Plant taxonomy | Biotechnology | Mycology | Plant Anatomy/Development | Plant Breeding/Biotechnology | Plant Systematics/Taxonomy/Biogeography | BiotechnologyFormatos físicos adicionales: Printed edition:: Sin título; Printed edition:: Sin títuloClasificación CDD: 579.135 Clasificación LoC:QK600-638Recursos en línea: Libro electrónicoTexto
Contenidos:
Preface -- Exploration of macrofungi in sub-tropical semi-evergreen Indian forest ecosystems -- A Global Overview of Edible Mushrooms -- Molecular characterization of wild mushrooms: a paradigm shift from morphotyping -- Antimicrobial and hepatoprotective activities of edible mushrooms -- Mushroom-mediated Protection from Oxidative Damage to DNA -- Chemical and bioactive profiling of wild edible mushrooms -- Biotechnological requirements for the commercial cultivation of macrofungi: substrate and casing layer -- Role of mushroom fungi in decolourization of industrial dyes and degradation of agrochemicals -- Mushrooms: Isolation and purification of exopolysaccharides -- Novel prospective of wild mushroom polysaccharides as potential prebiotics -- Pharmaceutic prodigy of ergosterol and protein profile of Ganoderma lucidum -- Application of Wild Macrofungi as Anticancer Therapeutics -- Recent advances in cultivation of edible mushrooms -- Medicinal mushrooms: Cultivation and pharmaceutical impact -- Biological control of microbial pathogens in edible mushrooms -- Cordycepin: A biotherapeutic molecule from medicinal mushroom -- Biosynthesis of Nanoparticles using Mushrooms -- Bioconversion and Biotransformation Efficiencies of Wild Macrofungi -- Wild macro-fungi from Northwest Himalayas: Future prospects and challenges -- Index.
En: Springer Nature eBookResumen: Mushrooms are fleshy fungi with a high prospective for the production of secondary metabolites including extracellular enzymes with high agricultural and biotechnological significance. Worldwide, they are well recognized as supplementary foods due to their high nutritional values and their medicinal importance, which includes their uses in exhibiting antioxidant and antimicrobial activities, immune enhancer, and to be effective for the treatment of several diseases including diabetes and few types of cancers as well. According to recent studies, extracellular enzymes produced by several white-rot fungal strains such as Phanerochaete chrysosporium, Pleurotus sajor-caju and several mushrooms have shown a high capacity to decolorize dyes that are very harmful for the environment. Moreover, wild macrofungi have the capability to synthesize nanoparticles which are more useful for the treatment of cancer, gene therapy, DNA analysis and biosensors. Wild macrofungi are extremely important model for basic biology and commercial manufacture.
Star ratings
    Valoración media: 0.0 (0 votos)
Existencias
Tipo de ítem Biblioteca actual Colección Signatura Copia número Estado Fecha de vencimiento Código de barras
Libro Electrónico Biblioteca Electrónica
Colección de Libros Electrónicos 1 No para préstamo

Acceso multiusuario

Preface -- Exploration of macrofungi in sub-tropical semi-evergreen Indian forest ecosystems -- A Global Overview of Edible Mushrooms -- Molecular characterization of wild mushrooms: a paradigm shift from morphotyping -- Antimicrobial and hepatoprotective activities of edible mushrooms -- Mushroom-mediated Protection from Oxidative Damage to DNA -- Chemical and bioactive profiling of wild edible mushrooms -- Biotechnological requirements for the commercial cultivation of macrofungi: substrate and casing layer -- Role of mushroom fungi in decolourization of industrial dyes and degradation of agrochemicals -- Mushrooms: Isolation and purification of exopolysaccharides -- Novel prospective of wild mushroom polysaccharides as potential prebiotics -- Pharmaceutic prodigy of ergosterol and protein profile of Ganoderma lucidum -- Application of Wild Macrofungi as Anticancer Therapeutics -- Recent advances in cultivation of edible mushrooms -- Medicinal mushrooms: Cultivation and pharmaceutical impact -- Biological control of microbial pathogens in edible mushrooms -- Cordycepin: A biotherapeutic molecule from medicinal mushroom -- Biosynthesis of Nanoparticles using Mushrooms -- Bioconversion and Biotransformation Efficiencies of Wild Macrofungi -- Wild macro-fungi from Northwest Himalayas: Future prospects and challenges -- Index.

Mushrooms are fleshy fungi with a high prospective for the production of secondary metabolites including extracellular enzymes with high agricultural and biotechnological significance. Worldwide, they are well recognized as supplementary foods due to their high nutritional values and their medicinal importance, which includes their uses in exhibiting antioxidant and antimicrobial activities, immune enhancer, and to be effective for the treatment of several diseases including diabetes and few types of cancers as well. According to recent studies, extracellular enzymes produced by several white-rot fungal strains such as Phanerochaete chrysosporium, Pleurotus sajor-caju and several mushrooms have shown a high capacity to decolorize dyes that are very harmful for the environment. Moreover, wild macrofungi have the capability to synthesize nanoparticles which are more useful for the treatment of cancer, gene therapy, DNA analysis and biosensors. Wild macrofungi are extremely important model for basic biology and commercial manufacture.

UABC ; Temporal ; 01/01/2021-12/31/2023.

Con tecnología Koha